Pharmaceutical

M&A in pharmaceutical in Australia remained flat in Q2 2023

In Australia pharmaceutical industry, there were 8 M&A deals announced in Q2 2023, worth a total value of $497.6m, according to GlobalData's Deals Database.

Jul 27, 2023 - 20:00
In Australia pharmaceutical industry, there were 8 M&A deals announced in Q2 2023, worth a total value of $497.6m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

M&A in pharmaceutical in Brazil decreased in Q2 2023

Next Article

How artificial intelligence M&A performed in the pharmaceutical industry in Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis after FDA nod

AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare...

Sep 20, 2024

Risk adjusted net present value: What is the current va...

Dec 15, 2024

Opinion: AI assurance labs intended to test health care technology have an equity problem

Opinion: AI assurance labs intended to test health care...

Feb 7, 2024